Keyphrases
Germ Cell Tumor
85%
Neuroblastoma
81%
Tumor
61%
Human Pluripotent Stem Cells (hPSCs)
59%
RAS-MAPK Pathway
56%
Tumor Protein p53 (TP53)
51%
Aberrations
44%
Genetic Aberrations
44%
Mediastinal Germ Cell Tumor
43%
Cisplatin Resistance
43%
Malignant Germ Cell Tumors
36%
Tumor Subtype
32%
Pluripotent Stem Cells
30%
Refractory Neuroblastoma
28%
Teratoma
28%
Human Germ Cells
27%
MEK Inhibitor (MEKi)
27%
Chromosome 11q
27%
Therapeutic Vulnerabilities
25%
Cell-based
25%
Pluripotent
25%
Stem Cell-derived
25%
Oncogene
24%
Cas9 Protein
24%
RAS-MAPK
21%
Bcl-2 Family
21%
Low Amplitude
21%
Copy number Gain
21%
Safety Issues
21%
Tumor Risk
21%
Cell Population
21%
Feeder-free Culture
21%
Chromosome 1q
21%
Murine Double Minute 4 (MDM4)
21%
MCM9
21%
Pathway mutation
21%
Loss Amplification
21%
Large Deletion
21%
Chromosomal Deletion
21%
Germ Cell Malignancy
21%
Tumor Progression
21%
Targeted Drugs
21%
Somatic Malignancy
21%
Checkpoint Kinase 1 (CHK1)
21%
Pediatric Cancer
21%
MYCN Amplification
21%
Chromosome-specific
21%
Germline Variants
21%
Mouse Embryonic Stem Cells (mESCs)
21%
Biallelic
21%
Biochemistry, Genetics and Molecular Biology
Stem Cell
77%
Germ Cell
50%
Cisplatin
43%
Mitogen-Activated Protein Kinase
43%
Genetics
38%
Chromosome 11q
32%
Teratoma
27%
Stem Cell Transplantation
25%
CRISPR/Cas9
24%
Chromosomal Aberration
24%
Genomics
24%
Oncogene
21%
Chromosome 1q
21%
MDM4
21%
Neuroendocrine Cell
21%
Kinase
21%
Phosphotransferase
21%
Tumor Progression
21%
Germline
21%
Aneuploidy
21%
Embryonic Stem Cell
21%
P53
16%
Chromosome 6
12%
Trisomy
12%
DNA Repair
12%
Carcinogenesis
10%
Vitronectin
10%
Human Chorionic Gonadotropin
10%
Polyploid
10%
Clonal Variation
10%
Tumor Marker
10%
Clonality
10%
Alpha-Fetoprotein
10%
DNA Methylation
10%
Growth, Development and Aging
10%
Functional Genomics
10%
Chromosome 6q
10%
Colony Forming Unit S
10%
RNA Sequence
10%
Adolescence
10%
Autosome
9%
Overall Survival
9%
Synteny
8%
Chromosome 12
8%
Tumor Suppressor Protein
8%
Wild Type
8%
Preclinical Study
7%
High Throughput Screening
7%
Survival Rate
7%
Target Cell
5%
Medicine and Dentistry
Germinoma
100%
Cisplatin
50%
Tumor
50%
Neoplasm
50%
Cancer
44%
Pluripotent Stem Cell
43%
Ganglioneuroblastoma
43%
Mediastinal Germ Cell Tumor
30%
Stem Cell Therapy
24%
Yolk Sac
21%
Cell Population
21%
Disease
21%
Mitogen-Activated Protein Kinase
21%
Checkpoint Kinase 1
21%
Chromosome 11q
21%
Recurrent Disease
21%
Lethality
21%
Pediatric Cancer
21%
Somatics
21%
Malignant Neoplasm
13%
Dentigerous Cyst
12%
Primary Tumor
12%
Human Pluripotent Stem Cell
10%
Carcinogenesis
10%
Diagnosis
10%
Heat Map
10%
Pediatrics
10%
Biological Marker
9%
Solid Malignant Neoplasm
9%
Protein P53
9%
Endodermal Sinus Tumor
8%
Diseases
8%
Chemotherapy
8%
Leiomyosarcoma
8%
In Vitro
8%
Treatment Option
7%
Minimal Residual Disease
7%
microRNA
7%
Chromosome 3p
7%
Genetic Screening
7%
Translational Research
7%
Testis Cancer
7%
Overall Survival
7%
Knock Out
6%
Infancy
5%
Target Cell
5%
Tumor Suppressor Protein
5%
Diabetes Mellitus
5%
Risk Stratification
5%
Medicine
5%
